Does ROLAPITANT Cause Therapy cessation? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Therapy cessation have been filed in association with ROLAPITANT (Varubi). This represents 1.2% of all adverse event reports for ROLAPITANT.
10
Reports of Therapy cessation with ROLAPITANT
1.2%
of all ROLAPITANT reports
0
Deaths
1
Hospitalizations
How Dangerous Is Therapy cessation From ROLAPITANT?
Of the 10 reports, 1 (10.0%) required hospitalization, and 1 (10.0%) were considered life-threatening.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROLAPITANT. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does ROLAPITANT Cause?
Death (241)
Flushing (92)
Nausea (80)
Dyspnoea (74)
Infusion related reaction (65)
Erythema (54)
Feeling hot (47)
Dizziness (45)
Hospitalisation (36)
Back pain (32)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
Which ROLAPITANT Alternatives Have Lower Therapy cessation Risk?
ROLAPITANT vs ROMIDEPSIN
ROLAPITANT vs ROMIPLOSTIM
ROLAPITANT vs ROMOSOZUMAB
ROLAPITANT vs ROMOSOZUMAB-AQQG
ROLAPITANT vs ROPEGINTERFERON ALFA-2B-NJFT